No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Baylor College of Medicine · Other
Who this trial is looking for
This trial is looking for individuals with Osteogenesis Imperfecta (OI) to understand the condition better and gather data for future studies. Participants will be assessed based on their medical history and unique characteristics of their type of OI.
Are You a Good Fit for This Trial?
Must not be takingBisphosphonatesCalcitoninCalcitriolFluoride
You may be able to join if
I have been diagnosed with Osteogenesis Imperfecta through DNA analysis
I have a clinical history and imaging that suggests I have Osteogenesis Imperfecta
I am between the ages of 3 to 17 and have scoliosis
I am 18 years or older and have scoliosis
I am female of reproductive age with a mutation causing Osteogenesis Imperfecta and planning for pregnancy
I am female of reproductive age who is pregnant and have pre-pregnancy bone density data
You may not be able to join if
I cannot attend scheduled follow up visits
I have a skeletal dysplasia other than Osteogenesis Imperfecta
I have Osteogenesis Imperfecta and another genetic or syndromic condition
I took a bone treatment medication within the last year
I have conditions affecting muscle or bone development, like cerebral palsy
I am in peri-menopause or menopause
I had a pregnancy with higher order multiples
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and…
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life.
The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Natural History Study:
Inclusion Criteria:
* Individuals with OI diagnosed by molecular (DNA) analysis OR
* Individuals whose clinical history and radiographs are highly suggestive of OI, but whose diagnosis has not been verified by biochemical or molecular studies
Exclusion criteria:
* Individu…
Natural History Study:
Inclusion Criteria:
* Individuals with OI diagnosed by molecular (DNA) analysis OR
* Individuals whose clinical history and radiographs are highly suggestive of OI, but whose diagnosis has not been verified by biochemical or molecular studies
Exclusion criteria:
* Individuals who are unable to return for their scheduled follow up visits.
* Individuals with skeletal dysplasias other than OI
* Individuals with OI and a second genetic or syndromic diagnosis
Vertebral Compression Fractures component Inclusion criteria
• Patients with nonsense or frameshift mutations in COL1A1 or COL1A2 of any age and clinical features of OI type I.
Exclusion criteria
* Use of a bone-acting treatment agent such as bisphosphonates, calcitonin, calcitriol, fluoride, etc., within one year of enrollment.
* Conditions other than Osteogenesis Imperfecta-HaploInsufficiency (OI-HI) affecting muscle and/or bone development (i.e. cerebral palsy, rickets)
* Nonsense or frame shift mutations in the final coding exons of COL1A1 or COL1A2, as this may not lead to haploinsufficiency.
Scoliosis in OI component:
Inclusion Criteria
* All study participants between the ages of 3 to 17 years OR
* Study participants 18 years and older with scoliosis
Dental and Craniofacial Abnormalities in OI component:
Inclusion Criteria • All subjects aged 3 years and older enrolled in the Longitudinal Study Exclusion Criteria Subjects who refuse the dental examination
Pregnancy in OI component:
Inclusion criteria
• Females of reproductive age with mutations in any known gene causing OI, who are contemplating pregnancy within 5 years of enrollment in the Natural History Study OR Females who are pregnant with available pre-pregnancy BMD (within 5 years prior to the first pregnancy visit).
Exclusion criteria
* Males
* Females who are peri-menopausal or menopausal
* Females who had gestations associated with higher order multiples.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.